Latest Breaking News On - மைக் மகலெந் - Page 6 : comparemela.com

Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition March 3, 2021 [Source: Getty Images North America] In a planned acquisition aimed at expanding its next-generation sequencing (NGS)-based capabilities in cancer diagnostics, Agilent Technologies announced yesterday it has agreed to buy Resolution Bioscience for up to $695 million. Once rolled into the company, Resolution Bioscience’s liquid biopsy platform will complement Agilent’s existing tissue-based companion diagnostics business. In total, Agilent says the addressable market for these diagnostic tests is expected to be $3 billion by 2025, and double that by the end of the decade. “By adding Resolution Bioscience’s liquid biopsy-based diagnostic technologies to our portfolio, we are strengthening Agilent’s offering to our biopharma customers and boosting the growth of our diagnostics and genomics business,” Agilent president and CEO Mike McMullen said in a statement.

Puneet soudaMike mcmullenLuxcel biosciencesMark liSanta claraFoundation medicineAgilent technologiesGuardant healthClinical laboratory improvement amendmentsElectronics firm agilent to sell chip unitResolution bioscienceMirati therapeuticsGuardant revealRoche owned foundation medicineExact sciencesSeahorse bioscience